Anavex Life Sciences Corp. Analysis
| Analyst Ratings |
|
Average Target Price
|
42.50
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.16
|
-0.18
|
-0.02
|
-12.50%
|
|
2022-06-30
|
-0.15
|
-0.16
|
-0.01
|
-6.67%
|
|
2022-03-31
|
-0.17
|
-0.14
|
0.03
|
17.65%
|
|
2021-12-31
|
-0.15
|
-0.14
|
0.01
|
6.67%
|
|
2021-09-30
|
-0.15
|
-0.15
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.13
|
-0.14
|
-0.01
|
-7.69%
|
|
2021-03-31
|
-0.14
|
-0.12
|
0.02
|
14.29%
|
|
2020-12-31
|
-0.11
|
-0.12
|
-0.01
|
-9.09%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.00
|
|
2022-09-30
|
-0.62
|
|
2021-09-30
|
-0.53
|
|
2020-09-30
|
-0.45
|
|
2019-09-30
|
-0.54
|
|
2018-09-30
|
-0.39
|
|
2017-09-30
|
-0.33
|
|
2016-09-30
|
-0.42
|
|
2015-09-30
|
-0.61
|
|
2014-09-30
|
-0.38
|
|
2013-09-30
|
-0.49
|
|
2012-09-30
|
-1.20
|
|
2011-09-30
|
-1.10
|
|
2010-09-30
|
-1.30
|
|
2009-09-30
|
-1.06
|
|
2008-09-30
|
-1.09
|
|
2007-09-30
|
-0.33
|
|
2006-09-30
|
0.00
|